KANSAS CLINICAL TRIAL SITES

2CARE (CoQ10 Phase 3)

Kansas City, Kansas

University of Kansas Medical Center

Carolyn Gray

913-588-6983

 

Wichita, Kansas

Hereditary Neurological Disease Centre

Greg Suter

316-721-9250

 

COHORT (Observational)

University of Kansas

Janice Broyles

913-588-0683

or

Hilary Dubinsky

913-945-5019

 

CREST-E (Creatine Phase 3)

University of Kansas Medical Center

Janice Broyles-Gorman

913-588-0683

 

HORIZON (Dimebon Phase 3)

Kansas City, Kansas

University of Kansas Medical Center

Carolyn Gray

913-588-6983

 

Wichita, Kansas

Hereditary Neurological Disease Centre

Greg Suter

316-721-9250

 

PREDICT (Observational)

Wichita, Kansas

Hereditary Neurological Disease Centre

Greg Suter

316-721-9250

 

(For a description of the Trial click on the Trial Name)